← Back to Search

Benzodiazepine

Diazepam for Alcohol Withdrawal Syndrome

N/A
Waitlist Available
Led By Matthew Sloan, MD, MSc
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-5 day treatment period
Awards & highlights

Study Summary

This trial will test whether it's possible to manage alcohol withdrawal symptoms remotely, and whether patients are satisfied with this method.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-5 day treatment period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-5 day treatment period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retention in treatment
Transfer to a higher level of care
Secondary outcome measures
Diazepam dose
Duration of active withdrawal treatment
Patient satisfaction with the telemedicine platform
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Symptom-triggered diazepam treatmentExperimental Treatment1 Intervention
Participants will be treated for a period of 3 days using a symptom-triggered withdrawal management protocol delivered over telemedicine. Participants who score 10 or above on the modified CIWA-Ar will be advised to take a specific dose of diazepam (either 10 or 20mg, at the clinician's discretion). Participants will be reassessed regularly over the 3-day period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diazepam
2016
Completed Phase 4
~2800

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,343 Previous Clinical Trials
26,453,063 Total Patients Enrolled
Centre for Addiction and Mental HealthLead Sponsor
355 Previous Clinical Trials
81,214 Total Patients Enrolled
Ontario Ministry of Health and Long Term CareOTHER_GOV
91 Previous Clinical Trials
107,994 Total Patients Enrolled

Media Library

Diazepam (Benzodiazepine) Clinical Trial Eligibility Overview. Trial Name: NCT04858490 — N/A
Alcohol Withdrawal Syndrome Research Study Groups: Symptom-triggered diazepam treatment
Alcohol Withdrawal Syndrome Clinical Trial 2023: Diazepam Highlights & Side Effects. Trial Name: NCT04858490 — N/A
Diazepam (Benzodiazepine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04858490 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Remote Treatment of Alcohol Withdrawal
2021. "Remote Treatment of Alcohol Withdrawal". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04858490.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top